VP of Research & Policy, Ewing Marion Kauffman Foundation
Partner, Third Rock Ventures
VP of Research and Special Initiatives, Google
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
What role will technology transfer play in the commercialization of the next generation of life sciences products? Biocom has asked Genetic Engineering News Editor-in-Chief John Sterling to moderate as leading experts discuss common barriers to commercialization in the life sciences industry, determine how we can overcome those barriers and what impact technology transfer will have on the future of the life sciences industry. Registration begins at 7 a.m., or register online here.